Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Lambert

Showing results (101-110 of 164) with videos related to

Pageof 17
Sort By:
Clinical Science (London, England : 1979)|January 22, 2017
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodiesGilles Lambert, Aurélie Thedrez, Mikaël Croyal, et al.
AIDS and Behavior|July 11, 2020
Combination HIV Prevention Strategies Among Montreal Gay, Bisexual, and Other Men Who Have Sex with Men in the PrEP Era: A Latent Class AnalysisCarla M Doyle, Mathieu Maheu-Giroux, Gilles Lambert, et al.
Journal of the American College of Cardiology|March 18, 2014
Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defectsGilles Lambert, Francine Petrides, Mathias Chatelais, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of EvolocumabAurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
Atherosclerosis|September 4, 2007
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South AfricaVivienne M Homer, A David Marais, Francesca Charlton, et al.
Scientific Reports|February 17, 2021
ABCC6 deficiency promotes dyslipidemia and atherosclerosisChristopher Brampton, Viola Pomozi, Li-Hsieh Chen, et al.
The Journal of Comparative Neurology|December 27, 2017
A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in miceDavid Couret, Steeve Bourane, Aurélie Catan, et al.
Epidemiology and Psychiatric Sciences|March 4, 2024
Using an intersectionality-based approach to evaluate mental health services use among gay, bisexual and other men who have sex with men in Montreal, Toronto and VancouverIvan Marbaniang, Erica E M Moodie, Eric Latimer, et al.
Bioengineering & Translational Medicine|July 22, 2024
Human induced pluripotent stem cells-derived liver organoids grown on a Biomimesys® hyaluronic acid-based hydroscaffold as a new model for studying human lipoprotein metabolismMeryl Roudaut, Amandine Caillaud, Zied Souguir, et al.
Journal of the American College of Cardiology|May 12, 2012
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control studyRoeland Huijgen, S Matthijs Boekholdt, Benoit J Arsenault, et al.
Pageof 17

Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Clinical Science (London, England : 1979)|January 22, 2017
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodiesGilles Lambert, Aurélie Thedrez, Mikaël Croyal, et al.
AIDS and Behavior|July 11, 2020
Combination HIV Prevention Strategies Among Montreal Gay, Bisexual, and Other Men Who Have Sex with Men in the PrEP Era: A Latent Class AnalysisCarla M Doyle, Mathieu Maheu-Giroux, Gilles Lambert, et al.
Journal of the American College of Cardiology|March 18, 2014
Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defectsGilles Lambert, Francine Petrides, Mathias Chatelais, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of EvolocumabAurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
Atherosclerosis|September 4, 2007
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South AfricaVivienne M Homer, A David Marais, Francesca Charlton, et al.
Scientific Reports|February 17, 2021
ABCC6 deficiency promotes dyslipidemia and atherosclerosisChristopher Brampton, Viola Pomozi, Li-Hsieh Chen, et al.
The Journal of Comparative Neurology|December 27, 2017
A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in miceDavid Couret, Steeve Bourane, Aurélie Catan, et al.
Epidemiology and Psychiatric Sciences|March 4, 2024
Using an intersectionality-based approach to evaluate mental health services use among gay, bisexual and other men who have sex with men in Montreal, Toronto and VancouverIvan Marbaniang, Erica E M Moodie, Eric Latimer, et al.
Bioengineering & Translational Medicine|July 22, 2024
Human induced pluripotent stem cells-derived liver organoids grown on a Biomimesys® hyaluronic acid-based hydroscaffold as a new model for studying human lipoprotein metabolismMeryl Roudaut, Amandine Caillaud, Zied Souguir, et al.
Journal of the American College of Cardiology|May 12, 2012
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control studyRoeland Huijgen, S Matthijs Boekholdt, Benoit J Arsenault, et al.
Pageof 17